Back
Corcept Therapeutics Stock Price Chart

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Buy
58
CORT
Corcept Therapeutics
Last Price:
$76.60
Seasonality Move:
13.16%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corcept Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 71.52 | Buy |
20-day SMA: | 72.66 | Buy |
50-day SMA: | 71.51 | Buy |
200-day SMA: | 59.08 | Buy |
8-day EMA: | 71.95 | Buy |
20-day EMA: | 71.99 | Buy |
50-day EMA: | 66.73 | Buy |
200-day EMA: | 34.24 | Buy |
Corcept Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 56.39 | Buy |
Chaikin Money Flow: | 898974 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (70.21 - 76.27) | Buy |
Bollinger Bands (100): | (59.82 - 77.04) | Buy |
Corcept Therapeutics Technical Analysis
Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 74.28 while CORT 8-day simple moving average is 71.52, which is a Buy signal.
-
The stock price of CORT is 74.28 while Corcept Therapeutics 20-day SMA is 72.66, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 71.51 while CORT share price is 74.28, making it a Buy technically.
-
CORT stock price is 74.28 and Corcept Therapeutics 200-day simple moving average is 59.08, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
58
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $74.28. The Score for CORT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
7.9B
Price in USD:
74.28
Share Volume:
967.3K
Corcept Therapeutics 52-Week Range
52-Week High:
117.33
52-Week Low:
29.42
Buy
58
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 74.28 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 74.28 while CORT 8-day exponential moving average is 71.95, which is a Buy signal.
-
The stock price of CORT is 74.28 while Corcept Therapeutics 20-day EMA is 71.99, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 66.73 while CORT share price is 74.28, making it a Buy technically.
-
CORT stock price is 74.28 and Corcept Therapeutics 200-day simple moving average is 34.24, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 56.39, which suggest Corcept Therapeutics is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics is (70.21 - 76.27), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (59.82 - 77.04), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.